Insulet (PODD) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $143.90 +3.55%
EPS Growth %: +24.8%
Financial Fact:
Net loss: -3.08M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +24.8%
Financial Fact:
Net loss: -3.08M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q1 EPS of ($0.19), inline with the analyst estimate. Revenue for the quarter came in at $81.2 million versus the consensus estimate of $79.06 million.
GUIDANCE:
Insulet sees Q2 2016 revenue of $81-84 million, versus the consensus of $82.3 million.
- For the year ending December 31, 2016, the Company is reaffirming its revenue guidance of $330 to $350 million
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
